Biosimilar Drugs Market 2016: Industry Analysis, Size, Share, Growth, Trends and Forecasts
The Biosimilar Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts. Since their commercial inception in the 1980s, biologic drugs have grown into a $200 Billion market, driven by their effectiveness in key therapeutic areas such as oncology, diabetes and rheumatoid arthritis. Unlike traditional small molecule drugs, biologic drugs are much harder to replicate and have allowed originators to maintain market dominance even after their patents have begun to expire. However, generic drug manufacturers are keen to invest...
View full press release